These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17465259)

  • 1. Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma.
    Kim MS; Cho WH; Song WS; Lee SY; Jeon DG
    Anticancer Res; 2007; 27(2):1171-8. PubMed ID: 17465259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
    Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
    Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results and prognostic factors in patients with malignant fibrous histiocytoma.
    Hsu HC; Huang EY; Wang CJ
    Acta Oncol; 2004; 43(6):530-5. PubMed ID: 15370609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of prognostic factors for malignant fibrous histiocytoma of bone].
    Li GX; Guo W; Yang RL; Qu HY; Tang S; Qi DW
    Zhonghua Wai Ke Za Zhi; 2011 Aug; 49(8):733-6. PubMed ID: 22168940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary malignant fibrous histiocytoma (myxofibrosarcoma/pleomorphic sarcoma not otherwise specified) of the breast: clinicopathologic study of 19 cases.
    Hartel PH; Bratthauer G; Hartel JV; Fanburg-Smith JC
    Ann Diagn Pathol; 2011 Dec; 15(6):407-13. PubMed ID: 21983422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
    Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
    J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression.
    Li YR; Akbari E; Tretiakova MS; Hart J; Akbari M; Urbanski SJ; Gao ZH
    Am J Surg Pathol; 2008 Aug; 32(8):1144-58. PubMed ID: 18545143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase.
    Gu J; Zhang S; Wu X; Shi J; Zhang B; Zhang X; Yang J; Obulkasim H; Duan F; Deng C; He J; Zou X; Ding Y
    Int J Clin Exp Pathol; 2015; 8(3):2876-87. PubMed ID: 26045796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant fibrous histiocytoma of the retroperitoneum--review of clinical course and histopathology].
    Ichihara K; Takahashi S; Takahashi A; Masumori N; Itoh N; Hasegawa T; Takagi Y; Taguchi K; Tsukamoto T
    Hinyokika Kiyo; 2006 Oct; 52(10):761-4. PubMed ID: 17131862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of pleomorphic sarcoma at University Malaya Medical Center--a fifteen-year review.
    Chan CY; Janarthan N; Vivek AS; Jayalakshmi P
    Med J Malaysia; 2008 Oct; 63(4):311-4. PubMed ID: 19385491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer.
    Musiał J; Sporny S; Nowicki A
    Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant fibrous histiocytoma of the sinonasal tract.
    Wang CP; Chang YL; Ting LL; Yang TL; Ko JY; Lou PJ
    Head Neck; 2009 Jan; 31(1):85-93. PubMed ID: 18853446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological vascular invasion by tumors is a risk factor for distant metastasis in malignant fibrous histiocytoma.
    Yonemoto T; Tatezaki S; Ishii T; Iwata S; Takeuchi Y; Araki A
    Anticancer Res; 2005; 25(2B):1337-42. PubMed ID: 15865088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant fibrous histiocytoma of the lung.
    Rzyman W; Jaskiewicz K; Murawski M; Sternau A; Marjanski T; Karmolinski A; Dziadziuszko R
    Thorac Cardiovasc Surg; 2007 Apr; 55(3):186-9. PubMed ID: 17410507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles in malignant fibrous histiocytomas: clues for differentiating 'spindle cell' and 'pleomorphic' subtypes.
    Scapolan M; Perin T; Wassermann B; Canzonieri V; Colombatti A; Italia F; Spessotto P
    Eur J Cancer; 2008 Jan; 44(2):298-309. PubMed ID: 18054831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant fibrous histiocytoma of the bladder. A literature review].
    Povo-Martín I; Gallego-Vilar D; Bosquet-Sanz M; Miralles-Aguado J; Gimeno-Argente V; Rodrigo-Aliaga M; Gallego-Gómez J
    Actas Urol Esp; 2010 Apr; 34(4):378-85. PubMed ID: 20470701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S; Kamo R; Harada T; Ishii M
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.